Education
About Us
Working with TipRanks
Follow Us
DENTSPLY SIRONA Inc (XRAY)
NASDAQ:XRAY
Earnings Data
Report Date
May 01, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.3Last Year’s EPS
0.42Same Quarter Last Year
Moderate Buy
Based on 15 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 27, 2025
|% Change Since: -18.50%
|Next Earnings Date:May 01, 2025
Earnings Call Sentiment|Negative
The earnings call outlined several areas of growth and strategic progress, particularly in Europe and the imaging segment. However, these were overshadowed by significant challenges in the Byte segment, U.S. sales decline, and macroeconomic pressures resulting in impairments and a cautious outlook for 2025.Company Guidance
During the Q4 2024 Dentsply Sirona earnings call, the company provided guidance that included an expectation for organic sales to decline by 2% to 4% in 2025, largely impacted by a negative contribution from Byte. Despite these anticipated challenges, Dentsply Sirona expects EBITDA margins to exceed 18% in 2025, with adjusted earnings per share projected to range between $1.80 and $2.00. The company also highlighted strategic decisions to improve performance, such as redeploying Byte resources to the SureSmile platform and exploring strategic alternatives for the Wellspect HealthCare business. Additionally, the company is undertaking initiatives to streamline its G&A footprint, which are not yet included in the 2025 outlook, but are expected to significantly reduce costs and align with market benchmarks.European Organic Sales Growth
In the fourth quarter, the company saw a return to organic sales growth in Europe of approximately 2%.
Imaging Segment Growth
Global growth in imaging was nearly 13%, driven by improved commercial execution and specific product relaunches.
SureSmile Expansion
The SureSmile segment continued to grow globally, achieving a nearly 4% increase over the prior year quarter and over 20% growth in Europe for Q4 and the full year.
Wellspect Performance
Wellspect exceeded estimated market growth rates, posting approximately 7% growth.
Strategic Board Additions
The Board was augmented with the addition of Dan Scavilla and Mike Barber, expected to aid in executing the transformation strategy.
Operational and Innovation Highlights
Completion of the U.S. launch of the MIS LYNX implant and a strong adoption of the DS Core platform, indicating progress in the company's digital ecosystem.
---
XRAY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
XRAY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 27, 2025 | $18.81 | $17.15 | -8.83% |
| Nov 07, 2024 | $23.78 | $17.12 | -28.01% |
| Jul 31, 2024 | $26.40 | $26.75 | +1.33% |
| May 02, 2024 | $29.56 | $27.80 | -5.95% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does DENTSPLY SIRONA Inc (XRAY) report earnings?
DENTSPLY SIRONA Inc (XRAY) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
What is DENTSPLY SIRONA Inc (XRAY) earnings time?
DENTSPLY SIRONA Inc (XRAY) earnings time is at May 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is XRAY EPS forecast?
XRAY EPS forecast for the fiscal quarter 2025 (Q1) is 0.3.
---